López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017;359: j5058.
Article PubMed PubMed Central Google Scholar
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.
Article CAS PubMed Google Scholar
Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation. A randomized clinical trial. JAMA. 2014;312:1988–98.
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year Outcomes after Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70:2964–75.
Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial fibrillation in CKD: Balancing the risks and benefits of anticoagulation. Am J Kidney Dis. 2013;62:615–32.
James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: A systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37–43.
Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovasc Interv Ther. 2020;35:209–17.
Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation. 2021;143:1754–62.
Article CAS PubMed Google Scholar
Chakravarty T, Leong D, Bhardwaj N, Singwine C, Zung L, Friedman J, et al. Zero-contrast Percutaneous left atrial appendage occlusion with WATCHMAN FLX device. JACC Clin Electrophysiol. 2023;9:1004–5.
Messas N, Ibrahim R. The Amplatzer amulet device: Technical Considerations and Procedural Approach. Interv Cardiol Clin. 2018;7:213–8.
Lam YY, Yan BP, Doshi SK, Li A, Zhang D, Kaya MG, et,al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LambreTM Device) in a canine model. Int J Cardiol, 2013;168:3996–4001.
Huang H, Liu Y, Xu Y, Wang Z, Li Y, Cao K, et al. Percutaneous left atrial appendage closure with the Lambre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC Cardiovasc Interv. 2017;10:2188–94.
Jingquan Z, Deyong L, Huimin C, Hua F, Xuebin H, Chenyang J, et al. Intracardiac echocardiography Chinese expert consensus. Front Cardiovasc Med. 2022;9:1012731.
Article PubMed PubMed Central Google Scholar
Nielsen-Kudsk JE, Berti S, Caprioglio F, Ronco F, Arzamendi D, Betts T, et al. Intracardiac echocardiography to guide Watchman FLX implantation: The ICE LAA study. JACC Cardiovasc Interv. 2023;16:643–51.
Perez RJ, Amin A, Yakubov SJ, Sanchez CE. First reported 4D volume intracardiac echocardiography guided left atrial appendage closure in the USA. Struct Heart. 2020;4:72–4.
Comments (0)